Year: 2013
Type: article
Abstract: BACKGROUND: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of extracellular amyloid-β peptide and intracellular tau. Here, we review data suggesting that prefibrillar tau oligomers mediate cognitive decline early in the disease. OBJECTIVE: It was our aim to study the presence of tau-positive pretangle neurons and correlate findings with cognitive test scores. METHODS: Pretangle antibodies (TOC1 and pS422) were applied to tissue containing cholinergic basal forebrain neurons from people who died with a premortem clinical diagnosis of no cognitive impairment, mild cognitive impairment and AD. RESULTS: Data lend support to the concept that tau oligomers are the toxic form of tau, that non-fibillar tau relates to cognitive dysfunction and that the earliest pretangle pathology occurs in neuritic processes. CONCLUSIONS: Clinicopathological findings highlight the importance of studying tau modifications in neuronal soma and neuritic processes, which may be the earliest pathological lesions that correlate with cognitive status.
Source: Neurodegenerative Diseases
DOI: 10.1159/000353687
Authors: Elliott J. Mufson, Sarah Ward, Lester Binder
Institutions: Rush University Medical Center, Northwestern University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
Funder: National Institute on Aging
OpenAlex ID: W1997729633
